BARRIER CREME - 1.5% 1.5 %
DIMETHICONE : 1.5 % · DIN 02144522 · HOLLISTER LIMITED
Health Canada status: CANCELLED POST MARKET
What is BARRIER CREME - 1.5%?
BARRIER CREME - 1.5% 1.5 % contains DIMETHICONE : 1.5 %. It is listed in the Health Canada Drug Product Database under DIN 02144522, held by HOLLISTER LIMITED, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 09-Sep-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02144522 |
|---|---|
| Brand name | BARRIER CREME - 1.5% |
| Generic / active ingredient | DIMETHICONE : 1.5 % |
| Manufacturer | HOLLISTER LIMITED |
| Strength | 1.5 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02AA SILICONE PRODUCTS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 09-Sep-2005 |
What can be used instead?
Other Canadian products sharing ATC code D02AA SILICONE PRODUCTS. 7 of 41 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BARRIERE CREAM 20% | 20 % | CREAM | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | DIN 02060841 |
| BAZA CLEANSE & PROTECT | 2 % | LOTION | COLOPLAST A/S | MARKETED | DIN 02243966 |
| CAVILON DURABLE BARRIER CREAM | 1.3 % | CREAM | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02455838 |
| CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE | 9 % | CREAM | LABORATOIRES LA ROCHE-POSAY CANADA | MARKETED | DIN 02527731 |
| COMFORT SHIELD | 3 % | WIPE | SAGE PRODUCTS LLC | MARKETED | DIN 02245871 |
| DIMETHICONE PROTECTANT | 5.0 % | CREAM | SMITH & NEPHEW INC | MARKETED | DIN 02301725 |
| PROSHIELD PLUS | 1 % | OINTMENT | SMITH & NEPHEW INC | MARKETED | DIN 02256975 |
| BABY FRESH WIPES WITH ULTRAGUARD 1% | 1 % | LOTION | SCOTT PAPER LIMITED | CANCELLED POST MARKET | DIN 02022761 |
| BARRIERE CRM 20% | 20 % | CREAM | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00253057 |
| CLEAN N MOIST - ASP-LIQ 1.5% | 1.5 % | LIQUID ; SPRAY | HOLLISTER LIMITED | CANCELLED POST MARKET | DIN 02144638 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.